You are searching for: hsa04014

---

T90572 Target Info	Target Name	Insulin-like growth factor-II (IGF2)
	Target type	Clinical trial Target
	Disease	Breast cancer; Prostate cancer;
	Drugs	Xentuzumab	Drug Info

T19852 Target Info	Target Name	Keratinocyte growth factor (FGF7)
	Target type	Clinical trial Target
	Disease	Solid tumour/cancer;
	Drugs	Keratinocyte growth factor	Drug Info

T03046 Target Info	Target Name	Mutated KRAS (mKRAS)
	Target type	Clinical trial Target
	Disease	Pancreatic cancer;
	Drugs	GI-4000 + gemcitabine	Drug Info

T00663 Target Info	Target Name	Stress-activated protein kinase JNK3 (JNK3)
	Target type	Patented-recorded Target
	Disease	Central nervous system injury;
	Drugs	7-azaindole derivative 6	Drug Info

T69375 Target Info	Target Name	Stress-activated protein kinase JNK2 (JNK2)
	Target type	Preclinical Target
	Disease	T-cell leukaemia;
	Drugs	PMID25991433-Compound-D2	Drug Info

T00348 Target Info	Target Name	ABL T315I mutant (ABL T315I)
	Target type	Patented-recorded Target
	Disease	Not Available
	Drugs	PMID25656651-Compound-42	Drug Info

T16538 Target Info	Target Name	EGFR T790M mutant (EGFR T790M)
	Target type	Successful Target
	Disease	Non-small-cell lung cancer; Melanoma;
	Drugs	Osimertinib	Drug Info

T63024 Target Info	Target Name	NF-kappa-B-activating kinase (TBK1)
	Target type	Patented-recorded Target
	Disease	Not Available
	Drugs	Pyrimidinyl compound 5	Drug Info

T32855 Target Info	Target Name	Neurotrophin-3 (NTF3)
	Target type	Discontinued Target
	Disease	Constipation; Central nervous system disease;
	Drugs	NT-3	Drug Info

T96736 Target Info	Target Name	Transforming protein RhoA (RHOA)
	Target type	Discontinued Target
	Disease	Solid tumour/cancer;
	Drugs	ES-285	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.